Clinical Trials on Cholangiocellular Carcinoma) (ICC)

Total 24027 results

Memorial Sloan Kettering Cancer Center
Washington University School of Medicine; Ohio State University; University of...

Completed

Hepatic Arterial Infusion With Floxuridine and Dexamethasone in Combination With Gemcitabine as Adjuvant Treatment After Resection of Intrahepatic Cholangiocarcinoma

Intrahepatic Cholangiocarcinoma | Peripheral Cholangiocarcinoma | Cholangiolar Carcinoma | Cholangiocellular Carcinoma) (ICC)

United States
Johannes Gutenberg University Mainz

Unknown

Selective Internal Radiotherapy (SIRT) Versus Transarterial Chemoembolisation (TACE) for the Treatment of Cholangiocellular Carcinoma (CCC).

Intrahepatic Cholangiocellular Carcinoma

Germany
Access Vascular Inc

Completed

A Comparative, Retrospective Chart Review of Intended Dwell Time of a PICC Line

PICC | Peripheral ICC

United States
University Hospital Dresden

Completed

Efficacy of Imatinib and 5-FU/Leucovorin in Patients With Advanced Carcinoma of the Gallbladder and Bile Duct

Advanced or Metastatic Cholangiocellular Carcinoma and Bile Duct

Germany
University of Zurich

Completed

Adjuvant Cisplatin Plus Gemcitabine in Operable Cholangiocellular Carcinoma.

Cholangiocellular Carcinoma

Switzerland
University of Zurich

Completed

Downsizing of Unresectable Cholangiocarcinoma by Combined Intravenous and Intra-arterial Chemotherapy

Cholangiocellular Carcinoma

Switzerland
Zhengang Yuan

Unknown

Bortezomib in Intrahepatic Cholangiocellular Carcinoma

Intrahepatic Cholangiocarcinoma

China
Memorial Sloan Kettering Cancer Center

Active, not recruiting

Hepatic Arterial Infusion (HAI) With Floxuridine (FUDR) and Dexamethasone (Dex) Combined With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic Cholangiocarcinoma (ICC)

Intrahepatic Cholangiocarcinoma | Cholangiocellular Carcinoma | Peripheral Cholangiocarcinoma | Cholangiolar Carcinoma

United States
Seton Healthcare Family
University of Texas at Austin; Dell Medical School at The University of Texas...

Withdrawn

Intraoperative Margin Assessment During Mohs Surgery

Basal Cell Carcinoma (BCC) | Squamous Cell Carcinoma (SCC)
Milton S. Hershey Medical Center

Completed

Complications Associated With Central Venous Access in the NSICU: PICC vs CVC (NSPVC)

Central Venous Catheter | Central Line | PICC | Neuro ICU | Neuroscience ICU | CVC

United States
Clarunis - Universitäres Bauchzentrum Basel

Completed

Radioactive Seed-guided Resection of Cholangiocellular Carcinoma in Cirrhotic Patients

Liver Cirrhosis | Liver Cancer

Switzerland
National Cancer Center, Korea

Completed

Comparison of Central Venous Pressures (CVPs) Measured From Peripherally Inserted Central Catheters (PICC) and CICC in Liver Transplantation Recipients (PICC)

Patients Cannulated With Both PICC and CICC. | The Rapidly Fluctuating Hemodynamics During LT.

Korea, Republic of
Pulse Biosciences, Inc.

Completed

CellFX Treat & Resect Low-Risk BCC Feasibility Study

BCC | BCC - Basal Cell Carcinoma | Excision Margin

United States
The First Affiliated Hospital of Zhengzhou University
First Affiliated Hospital of Xinjiang Medical University; Anyang Tumor Hospital and other collaborators

Recruiting

Treatment of Advanced Intrahepatic Cholangiocarcinoma (TAICC)

ICC

China
Abbott Medical Devices

Completed

Clinical Evaluation Of Remote Monitoring With Direct Alerts To Reduce Time From Event To Clinical Decision (REACT)

The Patient Meets ACC/AHA/ESC Guidelines for Implantable Cardioverter Defibrillator (ICD) or Cardiac Resynchronization Therapy (CRT-D) Device

United Kingdom, Germany
Teleflex
Duke University

Enrolling by invitation

Vascular Positioning System G4 Algorithm ECG Data Collection for Model Training Study

Peripheral ICC

United States
Memorial Sloan Kettering Cancer Center

Active, not recruiting

Use of Jet-injection in Photodynamic Therapy for Basal Cell Carcinoma

Basal Cell Carcinoma | Nodular Basal Cell Carcinoma | Superficial Basal Cell Carcinoma | BCC | BCC - Basal Cell Carcinoma | Basal Cell Cancer

United States
Southeast University, China

Completed

Radiation Stent Versus Self-expanding Metallic Stents (SEMS) for Palliative Treatment of Malignant Biliary Stricture

Pancreatic Cancer | Gallbladder Cancer | Cholangiocellular Carcinoma | Metastatic Carcinoma

China
University Hospital Dubrava

Completed

Quantitative Real-time Ultrasound Elastography for Characterisation of Liver Tumors

Hepatocellular Carcinoma | Cholangiocellular Carcinoma | Metastases | Focal Nodular Hyperplasia | Haemangioma

Croatia
Beijing InnoCare Pharma Tech Co., Ltd.

Recruiting

A Study of ICP-192 in Patients With FGFR2-Rearranged Unresectable or Metastatic Intrahepatic Cholangiocarcinoma

Intrahepatic Cholangiocarcinoma (ICC)

China
Seoul National University Hospital

Completed

Study of Axitinib in Patients With Recurred or Metastatic Adenoid Cystic Carcinoma (AxitinibACC)

Recurrent ACC, metastaticACC, Unreaectable ACC

Korea, Republic of
Hoffmann-La Roche

Completed

A Study to Determine Best Tumor Response With Trastuzumab Emtansine in Human Epidermal Growth Factor Receptor 2 (HER2) Overexpressing Solid Tumors (KAMELEON)

Bladder Cancer | Pancreas Cancer | Cholangiocellular Carcinoma

Spain, Italy, Netherlands, Slovakia
Shanghai Zhongshan Hospital

Not yet recruiting

Combining Chemoradiotherapy With Sintilimab in First-Line ICC

ICC

China
Genentech, Inc.

Recruiting

A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7502175 as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Solid Tumors

Melanoma | Cervical Cancer | HCC | Gastric Cancer | Esophageal Cancer | NSCLC | Urothelial Carcinoma | HNSCC | Locally Advanced or Metastatic Solid Tumors | TNBC | Clear Cell RCC

Korea, Republic of, Netherlands, Spain, United States, Australia, Canada, Belgium
BeiGene

Completed

Study of BGB-A317 in Participants With Previously Treated Unresectable HCC

Hepatocellular Carcinoma (HCC)

Spain, China, Taiwan, Germany, Italy, United Kingdom, France, Poland
Vejle Hospital

Recruiting

The Diagnostic Accuracy of Advanced Imaging in Identifying Suspected Skin Cancer (Basal Cell Carcinoma) Around the Eyes (dOCT-pBCC)

Skin Diseases | Eyelid Diseases | Eyelid Tumor | BCC | BCC - Basal Cell Carcinoma

Denmark
University of Aleppo
Aleppo University Hospital

Recruiting

The Efficacy and Safety of Using Intralesional 5-fluorouracil for Basal Cell Carcinoma

Basal Cell Carcinoma | BCC

Syrian Arab Republic
Oshadi Drug Administration

Completed

Safety and Efficacy of Oshadi D and Oshadi R in Basal Cell Carcinoma Patients Prior to Tumor Excision a Phase 2 Study

BCC

Israel
Biofrontera Bioscience GmbH
Accovion GmbH

Completed

Safety and Efficacy Study for the Treatment of Non-Aggressive Basal Cell Carcinoma With Photodynamic Therapy

Basal Cell Carcinoma (BCC)

Germany
New Mexico Cancer Care Alliance

Terminated

Gemcitabine, Oxaliplatin, Tarceva &/or Cisplatin in HCC & Biliary Tree Cancers (Gem-ox)

Hepatocellular Carcinoma | Bile Duct Cancer | Gallbladder Cancer | Cholangiocellular Carcinoma | Extrahepatic Bile Duct Cancer | Cholangiocarcinoma of the Extrahepatic Bile Duct | Periampullary Adenocarcinoma

United States
Tufts Medical Center
DUSA Pharmaceuticals, Inc.

Completed

Photodynamic Therapy to Treat Actinic Damage in Patients With Squamous Cell Carcinoma (SCC) of the Lip

Actinic Cheilitis | Squamous Cell Carcinoma In-situ (SCC-is) | Squamous Cell Carcinoma (SCC) | Photodynamic Therapy (PDT) | Mohs Surgery

United States
Biosceptre
TKL Research, Inc.

Completed

Investigation of the Safety and Tolerability of BSCT (Anti-nf-P2X7) 10% Ointment

Carcinoma, Basal Cell (BCC)
Carmel Medical Center

Unknown

Intralesional Cryosurgery for Basal Cell Carcinoma - a Feasibility Study

Basal Cell Carcinoma (BCC)

Israel
Charite University, Berlin, Germany
Bayer

Recruiting

Non-invasive MRI Subclassification of Heptocellular Carcinoma - HepCaSt-Study (HepCaSt)

MRI | HCC | Hepatocellular Carcinoma

Germany
National Cancer Institute (NCI)

Terminated

Capecitabine and Vorinostat in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer

Recurrent Hypopharyngeal Squamous Cell Carcinoma | Recurrent Laryngeal Squamous Cell Carcinoma | Recurrent Oral Cavity Squamous Cell Carcinoma | Recurrent Oropharyngeal Squamous Cell Carcinoma | Stage IVA Oral Cavity Squamous Cell Carcinoma | Stage IVA Laryngeal Squamous Cell Carcinoma | Stage... and other conditions

Canada, United States
InflaRx GmbH
Merck Sharp & Dohme LLC

Active, not recruiting

Non-comparative Study of IFX-1 Alone or IFX-1+Pembrolizumab in Patients With Locally Advanced or Metastatic cSCC.

SCC - Squamous Cell Carcinoma of Skin

United States, Spain, Germany, Belgium, France
National Cancer Institute (NCI)

Terminated

Cisplatin With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Recurrent Hypopharyngeal Squamous Cell Carcinoma | Recurrent Laryngeal Squamous Cell Carcinoma | Recurrent Oropharyngeal Squamous Cell Carcinoma | Recurrent Lip and Oral Cavity Squamous Cell Carcinoma | Recurrent Laryngeal Verrucous Carcinoma | Recurrent Metastatic Squamous Cell Carcinoma in... and other conditions

Canada
National Cancer Institute (NCI)

Completed

Temsirolimus With or Without Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer Who Did Not Respond to Previous Therapy (MAESTRO HN)

Recurrent Hypopharyngeal Squamous Cell Carcinoma | Recurrent Laryngeal Squamous Cell Carcinoma | Recurrent Oropharyngeal Squamous Cell Carcinoma | Salivary Gland Squamous Cell Carcinoma | Recurrent Lip and Oral Cavity Squamous Cell Carcinoma | Recurrent Nasopharyngeal Keratinizing Squamous... and other conditions

United States, China
Bispebjerg Hospital

Unknown

Laser Immunotherapy With and Without Topical Anti-PD1 in Basal Cell Carcinomas

Immune Response | Immunotherapy | BCC - Basal Cell Carcinoma | Ablative Fractionated Laser

Denmark
Wake Forest University Health Sciences
National Cancer Institute (NCI)

Completed

Prepare to Care, A Supported Self-Management Intervention for Head and Neck Cancer CaregiversHead and Neck Cancer

Recurrent Head and Neck Squamous Cell Carcinoma | Recurrent Hypopharyngeal Squamous Cell Carcinoma | Recurrent Laryngeal Squamous Cell Carcinoma | Caregiver | Salivary Gland Squamous Cell Carcinoma | Malignant Head and Neck Neoplasm | Recurrent Lip and Oral Cavity Squamous Cell Carcinoma | Stage... and other conditions

United States
iOMEDICO AG

Recruiting

Liver Cancer Registry Platform (JADE)

Hepatocellular Carcinoma (HCC) | Cholangiocarcinoma

Germany
Sidney Kimmel Cancer Center at Thomas Jefferson...
Bristol-Myers Squibb

Completed

Nivolumab, Carboplatin, and Paclitaxel in Treating Patients With Stage III-IV Head and Neck Squamous Cell Carcinoma That Can Be Removed by Surgery

Stage IVA Oral Cavity Squamous Cell Carcinoma | Stage IV Hypopharyngeal Squamous Cell Carcinoma | Stage IVA Laryngeal Squamous Cell Carcinoma | Stage IVA Oropharyngeal Squamous Cell Carcinoma | Stage IVB Laryngeal Squamous Cell Carcinoma | Stage IVB Oropharyngeal Squamous Cell Carcinoma | Stage... and other conditions

United States
Yehua Shen

Not yet recruiting

HAIC Combined With PD-L1 Plus Regorafenib in the Treatment of Advanced Hepatocellular Carcinoma After Immunotherapy Failure

HCC - Hepatocellular Carcinoma
Great Novel Therapeutics Biotech & Medicals Corporation

Recruiting

Chidamide + Regorafenib in Hepatocellular Carcinoma (HCC)

Hepatocellular Carcinoma (HCC)

Taiwan
National Health Research Institutes, Taiwan
National Taiwan University Hospital; Mackay Memorial Hospital; China Medical... and other collaborators

Recruiting

Nivolumab Plus Ipilimumab as Neoadjuvant Therapy for Hepatocellular Carcinoma (HCC)

Hepatocellular Carcinoma (HCC)

Taiwan
BeiGene

Completed

Phase 3 Study of Tislelizumab Versus Sorafenib in Participants With Unresectable HCC

Hepatocellular Carcinoma (HCC)

China, Italy, United States, Germany, Japan, Taiwan, Czechia, Spain, United Kingdom, France, Poland
Indiana University

Terminated

Y90 Radiation Segmentectomy vs SBRT for HCC (SBRT vs Y90)

Hepatocellular Carcinoma (HCC)

United States
Shanghai Henlius Biotech

Withdrawn

A Clinical Study to Compare the Efficacy and Safety of HLX10 in Combination With HLX04 Versus Sorafenib as the First-line Treatment in Patients With Locally Advanced or Metastatic HCC

Hepatocellular Carcinoma (HCC)

China
Eisai Limited
Merck Sharp & Dohme LLC

Completed

A Multicenter, Open-Label, Phase 3 Trial to Compare the Efficacy and Safety of Lenvatinib (E7080) Versus Sorafenib in First-line Treatment of Participants With Unresectable Hepatocellular Carcinoma

Hepatocellular Carcinoma (HCC)

Italy, Korea, Republic of, Poland, United States, Australia, Belgium, Canada, China, France, Germany, Hong Kong, Israel, Japan, Malaysia, Philippines, Russian Federation, Singapore, Spain, Taiwan, Thailand, United Kingdom
Transgene

Terminated

A Trial to Evaluate the Safety and Efficacy of the Combination of the Oncolytic Immunotherapy Pexa-Vec With the PD-1 Receptor Blocking Antibody Nivolumab in the First-line Treatment of Advanced Hepatocellular Carcinoma (HCC)

Hepatocellular Carcinoma (HCC)

France

Clinical Trials on Cholangiocellular Carcinoma) (ICC)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Latvia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations